GlassScriptPhysician profile
Sajid Farooq
NPI 1710275896
$3,131.92
in general payments reported to CMS, 2019-2025
17 companies · $663 in 2025
The $663 reported for 2025 was more than what 92% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.26 · 2022: $22.81 · 2023: $24.74 · 2024: $2,410 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,618 · Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,618.08 |
| Food and Beverage | $1,479.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,273.32 | 2024 | Ekosonic |
| Abbott Laboratories | $221.62 | 2024-2025 | Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $126.87 | 2025 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $116.94 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $55.41 | 2024-2025 | Tezspire, Tagrisso, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $47.89 | 2025 | Glassia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.15 | 2024 | Ofev |
| Insmed, INC. | $37.61 | 2025 | Arikayce |
| Pfizer INC. | $36.87 | 2025 | |
| Electromed, INC. | $31.71 | 2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $27.21 | 2025 | Dupixent |
| W. L. Gore & Associates, INC. | $24.74 | 2023 | Gore Cardioform Septal Occluder |
| Getinge USA Sales, LLC | $22.81 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.59 | 2024 | Nuzyra |
| Glaxosmithkline, LLC. | $20.97 | 2025 | Nucala |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.95 | 2025 | |
| Janssen Pharmaceuticals, INC | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajid Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.